PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: deSciner Business Network Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

deSciner Integrates Powerful Search Engine for the Life Sciences from Transinsight into OBBeC Portal - deSciner™ Business Network, the global B2B publishing and communications firm serving specialist scientific markets worldwide, has entered into an agreement with Transinsight to integrate its GoPubMed search engine into deSciner™ OBBeC® Portal
deSciner Integrates Powerful Search Engine for the Life Sciences from Transinsight into OBBeC Portal

 

NewswireToday - /newswire/ - Leicester, Leicestershire, United Kingdom, 2007/06/20 - deSciner™ Business Network, the global B2B publishing and communications firm serving specialist scientific markets worldwide, has entered into an agreement with Transinsight to integrate its GoPubMed search engine into deSciner™ OBBeC® Portal.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Developed by Transinsight in collaboration with the Technical University of Dresden, GoPubMed is an ontology-based search engine for the life sciences, with a ground-breaking new technology which leads to better and faster search results, for both complex and simple queries. In contrast to classical search engines, GoPubMed can answer questions using its background knowledge and can be configured for molecular biology, medicine, drug development, and food science. It can search literature repositories, web sites, third-party intranet and users’ desktops.

“We are extremely delighted to be working closely with Transinsight to integrate such a powerful search engine into OBBeC® Portal,” said Timoor El-Sheikh, Managing Director and CEO of deSciner™ Business Network. “We always strive to bring together advanced content search facilities into OBBeC® Portal (obbec.com), as well as other tools, to enhance our user experience in accessing vital information, news and reference material in relation to life sciences, technology and healthcare, all through a single online interface.”

About deSciner™ Business Network

deSciner™ Business Network (desciner.com) is an international knowledge-base and consultancy company delivering impartial and vendor-neutral media products, web sites and publications to specialist science and business sectors.

About Transinsight

Transinsight (transinsight.com) is a German based company providing solutions for knowledge based search. The award winning company works in close collaboration with the bioinformatics group of the Technical University Dresden. Transinsight and the bioinformatics group are co-located in a technology breeding building hosting groups dedicated to genomics, proteomics, biophysics, tissue engineering, cellular machines and bioinformatics.

Transinsight brings leading edge research to the global market. GoPubMed is the publicly available flagship product which for the first time shows the use of knowledge at an industry standard level.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: deSciner Business Network Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


deSciner Integrates Powerful Search Engine for the Life Sciences from Transinsight into OBBeC Portal

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Marie Deleuil - deSciner.com 
+44(0)11 6250 6063 enquiries[.]desciner.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any deSciner Business Network Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From deSciner Business Network Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)